The Latest Headlines at American Banking and Market News
Equities Analysts Offer Predictions for Coinbase Global, Inc.’s Q2 2024 Earnings (NASDAQ:COIN)
Coinbase Global, Inc. (NASDAQ:COIN – Free Report) – Equities research analysts at Singular Research issued their Q2 2024 earnings estimates for shares of Coinbase Global in a note issued to investors on Wednesday, May... More of this article »
Q2 2024 EPS Estimates for Clene Inc. (NASDAQ:CLNN) Decreased by Roth Capital
Clene Inc. (NASDAQ:CLNN – Free Report) – Stock analysts at Roth Capital lowered their Q2 2024 EPS estimates for Clene in a research report issued on Wednesday, May 8th. Roth Capital analyst J. Aschoff now expects that... More of this article »
ConocoPhillips (NYSE:COP) to Post Q2 2024 Earnings of $2.20 Per Share, Capital One Financial Forecasts
ConocoPhillips (NYSE:COP – Free Report) – Equities research analysts at Capital One Financial decreased their Q2 2024 earnings estimates for shares of ConocoPhillips in a research note issued on Thursday, May 9th. Capital... More of this article »
Roth Capital Analysts Reduce Earnings Estimates for California Resources Co. (NYSE:CRC)
California Resources Co. (NYSE:CRC – Free Report) – Equities research analysts at Roth Capital cut their Q2 2024 earnings per share estimates for California Resources in a research report issued to clients and investors... More of this article »
Brokers Issue Forecasts for Ducommun Incorporated’s Q2 2024 Earnings (NYSE:DCO)
Ducommun Incorporated (NYSE:DCO – Free Report) – Investment analysts at B. Riley lifted their Q2 2024 EPS estimates for shares of Ducommun in a report released on Thursday, May 9th. B. Riley analyst M. Crawford now... More of this article »
Q2 2024 EPS Estimates for DoubleDown Interactive Co., Ltd. (NASDAQ:DDI) Cut by Northland Capmk
DoubleDown Interactive Co., Ltd. (NASDAQ:DDI – Free Report) – Northland Capmk lowered their Q2 2024 EPS estimates for shares of DoubleDown Interactive in a note issued to investors on Thursday, May 9th. Northland Capmk... More of this article »
Brokers Set Expectations for CRISPR Therapeutics AG’s Q2 2024 Earnings (NASDAQ:CRSP)
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Analysts at Leerink Partnrs decreased their Q2 2024 EPS estimates for CRISPR Therapeutics in a research note issued on Wednesday, May 8th. Leerink Partnrs analyst... More of this article »
Commercial Vehicle Group, Inc. (NASDAQ:CVGI) to Post Q2 2024 Earnings of $0.14 Per Share, Barrington Research Forecasts
Commercial Vehicle Group, Inc. (NASDAQ:CVGI – Free Report) – Equities research analysts at Barrington Research decreased their Q2 2024 earnings per share estimates for Commercial Vehicle Group in a research report issued... More of this article »
Q2 2024 EPS Estimates for Design Therapeutics, Inc. (NASDAQ:DSGN) Lifted by Analyst
Design Therapeutics, Inc. (NASDAQ:DSGN – Free Report) – Analysts at Leerink Partnrs lifted their Q2 2024 earnings per share (EPS) estimates for Design Therapeutics in a note issued to investors on Wednesday, May 8th.... More of this article »
Esperion Therapeutics, Inc. (NASDAQ:ESPR) to Post Q2 2024 Earnings of ($0.16) Per Share, HC Wainwright Forecasts
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Equities research analysts at HC Wainwright boosted their Q2 2024 EPS estimates for Esperion Therapeutics in a report released on Wednesday, May 8th. HC Wainwright... More of this article »
HC Wainwright Comments on DBV Technologies S.A.’s Q2 2024 Earnings (NASDAQ:DBVT)
DBV Technologies S.A. (NASDAQ:DBVT – Free Report) – Equities research analysts at HC Wainwright increased their Q2 2024 earnings per share (EPS) estimates for shares of DBV Technologies in a report issued on Wednesday,... More of this article »
B. Riley Comments on Cytokinetics, Incorporated’s Q2 2024 Earnings (NASDAQ:CYTK)
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Stock analysts at B. Riley lifted their Q2 2024 earnings per share estimates for shares of Cytokinetics in a research note issued on Thursday, May 9th. B. Riley... More of this article »
Q2 2024 EPS Estimates for Denali Therapeutics Inc. (NASDAQ:DNLI) Increased by Analyst
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Stock analysts at Wedbush raised their Q2 2024 EPS estimates for Denali Therapeutics in a research report issued on Wednesday, May 8th. Wedbush analyst L. Chico... More of this article »